Genetic effect of single-nucleotide polymorphisms in the PPARGC1B gene on airway hyperreactivity in asthmatic patients

Clinical and Experimental Allergy

Volumn 41, Issue 11, 2011, Pages 1533-1544

  Lee, S H ^a   Jang, A S ^a   Woo Park, S ^a   Park, J S ^a   Kim, Y K ^b   Uh, S T ^b   Kim, Y H ^b   Chung, I Y ^c   Park, B L ^d   Shin, H D ^d,e   Park, C S ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Hanyang University   (South Korea)

^d SNP Genetics Inc   (South Korea)

^e Sogang University   (South Korea)

Author keywords

Asthma; Methacholine; PCR; PPARGC1B; SNPs

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA;

ADOLESCENT; ADULT; AGED; AIRWAY HYPERREACTIVITY; ALLELE; ARTICLE; ASTHMA; CHILD; DNA SEQUENCE; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; BASE SEQUENCE; BINDING SITES; CARRIER PROTEINS; CELL LINE; CHILD; CHILD, PRESCHOOL; EXONS; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 80054049939     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03801.x     Document Type: Article

References (43)

1. Bateman ED, Hurd SS, Barnes PJet al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-78.
2. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164:S28-38.
3. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997; 156:229-33.
4. Lambert RK, Wiggs BR, Kuwano K, Hogg JC, Pare PD. Functional significance of increased airway smooth muscle in asthma and COPD. J Appl Physiol 1993; 74:2771-81.
5. Leigh R, Ellis R, Wattie Jet al. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 2002; 27:526-35.
6. Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST. Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003; 111:215-25; quiz 26.
7. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004; 22:789-815.
8. Roth M, Black JL. Transcription factors in asthma: are transcription factors a new target for asthma therapy? Curr Drug Targets 2006; 7:589-95.
9. Rahman I, MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax 1998; 53:601-12.
10. Kressler D, Schreiber SN, Knutti D, Kralli A. The PGC-1-related protein PERC is a selective coactivator of estrogen receptor alpha. J Biol Chem 2002; 277:13918-25.
11. Kamei Y, Ohizumi H, Fujitani Yet al. PPAR gamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc Natl Acad Sci USA 2003; 100:12378-83.
12. Lin J, Puigserver P, Donovan J, Tarr P, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem 2002; 277:1645-8.
13. Andersson U, Scarpulla RC. Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol Cell Biol 2001; 21:3738-49.
14. Postma DS, Bleecker ER, Amelung PJet al. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995; 333:894-900.
15. The Collaborative Study on the Genetics of Asthma (CSGA). A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Genet 1997; 15:389-92.
16. Xu J, Meyers DA, Ober Cet al. Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: collaborative study on the genetics of asthma. Am J Hum Genet 2001; 68:1437-46.
17. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978; 118:1-120.
18. Park BL, Kim LH, Choi YHet al. Interleukin 3 (IL3) polymorphisms associated with decreased risk of asthma and atopy. J Hum Genet 2004; 49:517-27.
19. Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999; 14:143-9.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8.
22. Flores-Delgado G, Bringas P, Buckley S, Anderson KD, Warburton D. Nongenomic estrogen action in human lung myofibroblasts. Biochem Biophys Res Commun 2001; 283:661-7.
23. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117:331-41.
24. Stephens M, Smith NJ, Donnelly P.A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-89.
25. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74:765-9.
26. Andersen G, Wegner L, Yanagisawa Ket al. Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity. J Med Genet 2005; 42:402-7.
27. Wirtenberger M, Tchatchou S, Hemminki Ket al. Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer. Carcinogenesis 2006; 27:2201-8.
28. Roorda RJ, Gerritsen J, van Aalderen WMet al. Follow-up of asthma from childhood to adulthood: influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood. J Allergy Clin Immunol 1994; 93:575-84.
29. Godden DJ, Ross S, Abdalla Met al. Outcome of wheeze in childhood. Symptoms and pulmonary function 25 years later. Am J Respir Crit Care Med 1994; 149:106-12.
30. Vrieze A, Postma DS, Kerstjens HA. Perimenstrual asthma: a syndrome without known cause or cure. J Allergy Clin Immunol 2003; 112:271-82.
31. Oguzulgen IK, Turktas H, Erbas D. Airway inflammation in premenstrual asthma. J Asthma 2002; 39:517-22.
32. Eliasson O, Scherzer HH, DeGraff ACJr. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol 1986; 77:87-94.
33. Vachier I, Chiappara G, Vignola AMet al. Glucocorticoid receptors in bronchial epithelial cells in asthma. Am J Respir Crit Care Med 1998; 158:963-70.
34. Schaaf MJ, Cidlowski JA. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 2002; 83:37-48.
35. Adcock IM. Molecular mechanisms of glucocorticosteroid actions. Pulm Pharmacol Ther 2000; 13:115-26.
36. Terzano C, Morano S, Ceccarelli Det al. Effect of insulin on airway responsiveness in patients with type 2 diabetes mellitus: a cohort study. J Asthma 2009; 46:703-7.
37. Cavalher-Machado SC, de Lima WT, Damazo ASet al. Down-regulation of mast cell activation and airway reactivity in diabetic rats: role of insulin. Eur Respir J 2004; 24:552-8.
38. Staiger H, Stefan N, Machicao F, Fritsche A, Haring HU.PPARGC1A mRNA levels of in vitro differentiated human skeletal muscle cells are negatively associated with the plasma oleate concentrations of the donors. Diabetologia 2006; 49:212-4.
39. Araujo LM, Lefort J, Nahori MAet al. Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells. Eur J Immunol 2004; 34:327-35.
40. Woerly G, Honda K, Loyens Met al. Peroxisome proliferator-activated receptors alpha, gamma down-regulate allergic inflammation and eosinophil activation. J Exp Med 2003; 198:411-21.
41. Huang TH, Razmovski-Naumovski V, Kota BP, Lin DS, Roufogalis BD. The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases. Respir Res 2005; 6:102.
42. Oh SH, Park SM, Park JSet al. Association analysis of peroxisome proliferator-activated receptors gamma gene polymorphisms with asprin hypersensitivity in asthmatics. Allergy Asthma Immunol Res 2009; 1:30-5.
43. Oh SH, Park SM, Lee YHet al. Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms with the development of asthma. Respir Med 2009; 103:1020-4.